[Study on quality status of mineral medicine Calamina].

Zhongguo Zhong Yao Za Zhi

Beijing Key Laboratory of Traditional Chinese Medicine Quality Evaluation, School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China.

Published: January 2020

AI Article Synopsis

  • The paper discusses quality issues found in market samples of mineral medicine Calamina and calcined Calamina and proposes solutions based on analysis results.
  • XRD analysis and tests from the Chinese Pharmacopoeia confirmed the authenticity of samples, while various spectrometry methods identified impurity and harmful elements present.
  • Key findings indicate a prevalence of fake products, inconsistency with pharmacopoeia standards, and high levels of harmful elements like lead and cadmium, leading to recommended actions for better regulation and quality control.

Article Abstract

In this paper, some quality problems of mineral medicine Calamina and calcined Calamina have been discussed after determination and analysis of the quality parameters of a large number of market samples, and the countermeasures are put forward. According to the XRD results, as well as the results of tests included in Chinese Pharmacopoeia(2015 edition), the authenticity of Calamina and calcined Calamina samples were identified. The content of zinc oxide in samples were determined by the method of determination in Chinese Pharmacopoeia. Individually, inductively coupled plasma mass spectrometry(ICP-MS), inductively coupled plasma atomic emission spectrometry(ICP-AES) and atomic fluorescence spectrometry(AFS) methods were used for the determination of impurity elements and harmful elements in Calamina and calcined Calamina samples. Four kinds of impurity elements of magnesium(Mg), iron(Fe), aluminum(Al), calcium(Ca) and five harmful elements such as lead(Pb), cadmium(Cd), arsenic(As), copper(Cu), mercury(Hg) were measured. The study showed that: ① Fake Calamina products on the market were overflowing; ② The mineral origin of the mainstream Calamina in the market is inconsistent with that stipulated in Chinese Pharmacopoeia(2015 edition); ③ The contents of harmful elements Pb and Cd in Calamina and calcined Calamina are generally higher, while the contents of harmful elements As and Cu in some inferior Calaminae are higher; ④ Parts of calcined Calamina were improperly or inadequately processed. In view of these quality problems, the countermeasures are put forward as follows: ① It is suggested that hydrozincite should be approved as the mineral source of Calamina, and be included by Chinese Pharmacopoeia; ② Strengthen the research on the specificity of Calamina identification methods to improve the quality control level; ③ Strengthen the research on the processing of Calamina, and formulate the limit standards for the content of Pb and Cd in Calamina; ④ Carry out research on the artificial synthesis of Calamina and calcined Calamina, in order to cope with the current shortage of Calamina resources and ensure the sustainable development of Calamina medicinal materials.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20191031.201DOI Listing

Publication Analysis

Top Keywords

calcined calamina
24
calamina calcined
20
calamina
19
harmful elements
16
mineral medicine
8
quality problems
8
countermeasures forward
8
included chinese
8
chinese pharmacopoeia2015
8
pharmacopoeia2015 edition
8

Similar Publications

[Study on quality status of mineral medicine Calamina].

Zhongguo Zhong Yao Za Zhi

January 2020

Beijing Key Laboratory of Traditional Chinese Medicine Quality Evaluation, School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China.

Article Synopsis
  • The paper discusses quality issues found in market samples of mineral medicine Calamina and calcined Calamina and proposes solutions based on analysis results.
  • XRD analysis and tests from the Chinese Pharmacopoeia confirmed the authenticity of samples, while various spectrometry methods identified impurity and harmful elements present.
  • Key findings indicate a prevalence of fake products, inconsistency with pharmacopoeia standards, and high levels of harmful elements like lead and cadmium, leading to recommended actions for better regulation and quality control.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!